The healthcare arm of Draftfcb Ulka has brought on board Dr Sushil Motwani as Business Head. Following this appointment, the agency plans to further strengthen its healthcare offering and build on its current base of clients.
The healthcare division of Draftfcb Ulka recently bagged Astra Zeneca’s branded generics business. AstraZeneca, an innovation driven organisation, is now aiming at inorganic growth by launching generic brands in the international markets.
Motwani would be spearheading the agency’s communication efforts in this direction, which would involve doctor communication developed in India for the international markets.
Motwani brings with him a medical background, combined with 12 years of experience both in product management and agency. In his earlier assignment, Motwani has steered many communication programmes with clients like Bayer Diabetes Care, Biogen Idec, Pfizer, Aristo, Novartis, Galderma and Lupin, working closely with the marketing teams to build successful, clutter-breaking campaigns addressing the doctor, sales force and the patients.
Some of the brands currently handled by Draftfcb Ulka include Digene, Pediasure, Vicryl, Anacin, and Brufen, among others.